UBS Group’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.24M | Sell |
|
|||||
|
2025
Q1 | $5.21M | Sell |
|
|||||
|
2024
Q4 | $5.29M | Sell |
|
|||||
|
2024
Q3 | $5.89M | Sell |
|
|||||
|
2024
Q2 | $5.8M | Sell |
|
|||||
|
2024
Q1 | $6.11M | Buy |
|
|||||
|
2023
Q4 | $4.35M | Sell |
|
|||||
|
2023
Q3 | $4.5M | Buy |
|
|||||
|
2023
Q2 | $3.46M | Buy |
|
|||||
|
2023
Q1 | $3.49M | Buy |
|
|||||
|
2022
Q4 | $2.84M | Sell |
|
|||||
|
2022
Q3 | $6.34M | Buy |
|
|||||
|
2022
Q2 | $6.78M | Buy |
|
|||||
|
2022
Q1 | $5.81M | Buy |
|
|||||
|
2021
Q4 | $5.31M | Buy |
|
|||||
|
2021
Q3 | $5.16M | Buy |
|
|||||
|
2021
Q2 | $5.14M | Buy |
|
|||||
|
2021
Q1 | $4.79M | Buy |
|
|||||
|
2020
Q4 | $4.92M | Buy |
|
|||||
|
2020
Q3 | $4.38M | Buy |
|
|||||
|
2020
Q2 | $3.75M | Buy |
|
|||||
|
2020
Q1 | $2.85M | Buy |
|
|||||
|
2019
Q4 | $2.15M | Buy |
|
|||||
|
2019
Q3 | $1.92M | Buy |
|
|||||
|
2019
Q2 | $1.77M | Sell |
|
|||||
|
2019
Q1 | $2.14M | Buy |
|
|||||
|
2018
Q4 | $1.88M | Buy |
|
|||||
|
2018
Q3 | $1.79M | Buy |
|
|||||
|
2018
Q2 | $1.58M | Sell |
|
|||||
|
2018
Q1 | $1.46M | Sell |
|
|||||
|
2017
Q4 | $1.73M | Buy |
|
|||||
|
2017
Q3 | $1.36M | Buy |
|
|||||
|
2017
Q2 | $1.34M | Buy |
|
|||||
|
2017
Q1 | $1.19M | Buy |
|
|||||
|
2016
Q4 | $914K | Buy |
|
|||||
|
2016
Q3 | $862K | Buy |
|
|||||
|
2016
Q2 | $754K | Buy |
|
|||||
|
2016
Q1 | $658K | Sell |
|
|||||
|
2015
Q4 | $738K | Sell |
|
|||||
|
2015
Q3 | $764K | Buy |
|
|||||
|
2015
Q2 | $765K | Sell |
|
|||||
|
2015
Q1 | $834K | Buy |
|
|||||
|
2014
Q4 | $793K | Buy |
|